Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Clarithromycin
- Therapeutic area
- Anti-infectives
- Drug class
- Macrolide antibacterials
- ATC
- J01FA
- Strength
- 500 mg
- Dosage form
- Tablet
- Pack
- 10
- Registration no.
- 043941
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-10-09 03:22
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Vestire 500 mg tablet
Vestire 500 mg tablet contains Clarithromycin 500 mg. It is registered with DRAP by NAVEGAL LABORATORIES (registration no. 043941). Its official price is PKR 821.73 for a pack of 10, about PKR 82.17 per tablet. This price has applied since 30 July 2026. Vestire is also available as 250 mg tablet. 132 other brands of Clarithromycin 500 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Other strengths of Vestire
Other brands of Clarithromycin 500 mg
Official price over time
No change in the official DRAP price is recorded for this pack (10). Current price PKR 821.73, effective 30 Jul 2026.
Cite this price history
MedInfoBase. Vestire 500 mg, 10: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/vestire-500-mg-043941-10-navegal-laboratories/ (accessed 9 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 821.73 | 2026-07-30 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 043941Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
